鹦鹉螺体育 NLS 深 沪
等待开盘 12-20 09:30:00 美东时间
0.8204
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.8204
- 总市值 2960.82万
- 52周最高 2.17
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.641
- 委 比 0.00%
- 总股本 3609.00万
- 历史最高 31.38
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.641
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nautilus Biotechnology Regains Nasdaq Compliance
Nautilus Biotechnolgy ( ($NAUT) ) has shared an announcement. On November 3, 20...
11-04 19:42
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
Nautilus Biotechnology and the Buck Institute for Research on Aging have successfully installed and tested Nautilus' first external field evaluation unit, generating highly reproducible tau proteoform data from neurodegenerative disease samples. This collaboration, leveraging Nautilus' single-molecule proteomics platform, marks a significant advancement in proteomics technology, offering new insights into tau biology and its role in neurodegenera...
11-03 13:00
NLS Pharmaceutics to execute 1-for-10 reverse share split
Swiss drugmaker NLS Pharmaceutics (NASDAQ:NLSP) plans to implement a reverse share split of its issued and outstanding common shares, par value CHF 0.03 per share, at a ratio of 1-for-10. The shares a...
10-29 18:22
Nautilus Biotechnology Advances Toward 2026 Commercial Launch
Nautilus Biotechnolgy, Inc. ( ($NAUT) ) has released its Q3 earnings. Here is a...
10-29 12:29
Nautilus Biotech Earnings Call Highlights Strategic Progress
Nautilus Biotechnolgy, Inc. (($NAUT)) has held its Q3 earnings call. Read on fo...
10-29 08:23
Earnings Scheduled For October 28, 2025
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
10-28 19:11
Nautilus Biotechnology Q3 EPS $(0.11) Beats $(0.15) Estimate. Cash And Equivalents Of $168.5M
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 15.38 percent increase over losses of $(0.13) per share
10-28 18:16
NLS Pharmaceutics, Kadimastem Receive Approval To List Common Shares On Nasdaq After Merger Under NewcelX Name, NCEL Ticker
NLS Pharmaceutics Ltd. (NASDAQ:NLSP) (NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system ("CNS") disorders, and Kadimastem Ltd. (TASE:
10-23 18:04
Navios Maritime Partners L.P. Announces Recent Fleet Developments
Navios Maritime Partners L.P. 宣布出售三艘船舶，总收益约6910万美元，并交付一艘MR2型成品油船，租期五年，日租金22669美元。公司已与三艘4250TEU集装箱船和两艘MR2成品油船签订长期租赁合同，预期收入1.139亿美元。当前 fleet包括172艘船，总运力1510万载重吨和287243TEU，平均船龄9.7年。公司已签订租赁协议，预期2025年最后半年和2026年收入分别为5.804亿和7.499亿美元，日均租金分别为24399和28092美元，未来收入达36亿美元。
10-16 20:06
